MedPath

Medrobotics Corporation

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Post-Market Clinical Follow-Up to Access & Visualize the Anus, Rectum, & Distal Colon During Transanal Procedures

Conditions
Disease or Lesions of the Anus, Rectum, or Distal Colon
First Posted Date
2017-10-26
Last Posted Date
2019-08-13
Lead Sponsor
Medrobotics Corporation
Target Recruit Count
20
Registration Number
NCT03323060
Locations
🇺🇸

Univsersity of Nevada School of Medicine, Las Vegas, Nevada, United States

🇺🇸

Icahn School of Medicine at Mount Sinai, New York, New York, United States

A Post-Market Clinical Trial for Access and Visualization of the Oropharynx, Hypopharynx and Larynx During Transoral Procedures

Completed
Conditions
OSA
Oral Disease
Oropharyngeal Neoplasms
Hypopharyngeal Neoplasms
First Posted Date
2014-10-13
Last Posted Date
2016-03-16
Lead Sponsor
Medrobotics Corporation
Target Recruit Count
80
Registration Number
NCT02262247
Locations
🇧🇪

University Hospital of Louvain at Mont-Godinne, Yvoir, Belgium

🇩🇪

University Hospital Ulm, Ulm, Baden-Württemberg, Germany

🇩🇪

University Hosptial Giessen and Marburg, Marburg, Baldingerstraße, Germany

and more 1 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.